Mark G. Edwards, Director at ACELRX PHARMACEUTICALS INC (ACRX), bought 30,000 shares at $1.90 ($57K) on 2017-11-14, disclosed to the SEC on 2017-11-15.
Open-market purchase of $57k ACRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| ACRX | BUY | 2019-03-12 | $114K | — | Filing → |
| ACRX | BUY | 2018-11-15 | $58K | — | Filing → |
| ACRX | BUY | 2018-08-08 | $15K | — | Filing → |